RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 137 filers reported holding RELAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $235,000 | -11.0% | 10,499 | -33.3% | 0.09% | -3.3% |
| Q2 2022 | $264,000 | -43.2% | 15,749 | +1.3% | 0.09% | -36.1% |
| Q1 2022 | $465,000 | -5.3% | 15,549 | -2.8% | 0.14% | +12.5% |
| Q4 2021 | $491,000 | +21.5% | 15,989 | +24.9% | 0.13% | +16.4% |
| Q3 2021 | $404,000 | -7.3% | 12,799 | +7.5% | 0.11% | -10.6% |
| Q2 2021 | $436,000 | +16.3% | 11,909 | +9.8% | 0.12% | +7.0% |
| Q1 2021 | $375,000 | +10.0% | 10,849 | +32.0% | 0.12% | +7.5% |
| Q4 2020 | $341,000 | +18.0% | 8,216 | +20.9% | 0.11% | +0.9% |
| Q3 2020 | $289,000 | – | 6,796 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |